Startup Dossier
Coave Therapeutics
Clinical-stage biotechnology company developing gene therapies for ocular and central nervous system diseases.
active
Typestartup
SectorBioTech
LocationParis
About
Clinical-stage biotechnology company developing gene therapies for ocular and central nervous system diseases.
Structural DNA
Legal Name
Coave Therapeutics
SIREN
800830721
Founders & Team
Funding Lineage
Series A
Novo Holdings (Lead)
€32.0M
Jan 2025
Series B
eureKARE (Lead)
€33.0M
Jul 2021
Programs
i-Lab
2015